165 related articles for article (PubMed ID: 25089376)
1. The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST.
Yip R; Henschke CI; Yankelevitz DF; Boffetta P; Smith JP;
Eur J Cancer Prev; 2015 May; 24(3):201-8. PubMed ID: 25089376
[TBL] [Abstract][Full Text] [Related]
2. The outcome differences of CT screening for lung cancer pre and post following an algorithm in Zhuhai, China.
Liu X; Liang M; Wang Y; Chen K; Chen X; Qin P; He J; Yi X
Lung Cancer; 2011 Aug; 73(2):230-6. PubMed ID: 21168238
[TBL] [Abstract][Full Text] [Related]
3. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.
Yip R; Henschke CI; Yankelevitz DF; Smith JP
Radiology; 2014 Nov; 273(2):591-6. PubMed ID: 24955929
[TBL] [Abstract][Full Text] [Related]
4. Computed tomography screening: the international early lung cancer action program experience.
Henschke CI; Boffetta P; Yankelevitz DF; Altorki N
Thorac Surg Clin; 2015 May; 25(2):129-43. PubMed ID: 25901557
[TBL] [Abstract][Full Text] [Related]
5. Inconsistencies in findings from the early lung cancer action project studies of lung cancer screening.
Bach PB
J Natl Cancer Inst; 2011 Jul; 103(13):1002-6. PubMed ID: 21685356
[TBL] [Abstract][Full Text] [Related]
6. Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer.
Flores R; Bauer T; Aye R; Andaz S; Kohman L; Sheppard B; Mayfield W; Thurer R; Smith M; Korst R; Straznicka M; Grannis F; Pass H; Connery C; Yip R; Smith JP; Yankelevitz D; Henschke C; Altorki N;
J Thorac Cardiovasc Surg; 2014 May; 147(5):1619-26. PubMed ID: 24332102
[TBL] [Abstract][Full Text] [Related]
7. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
8. Estimation of the tumor size at cure threshold among aggressive non-small cell lung cancers (NSCLCs): evidence from the surveillance, epidemiology, and end results (SEER) program and the national lung screening trial (NLST).
Goldwasser DL
Int J Cancer; 2017 Mar; 140(6):1280-1292. PubMed ID: 27925181
[TBL] [Abstract][Full Text] [Related]
9. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
10. Screening for lung cancer: the US studies.
Midthun DE; Jett JR
J Surg Oncol; 2013 Oct; 108(5):275-9. PubMed ID: 23918530
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer screening using low-dose CT: the current national landscape.
Eberth JM; Qiu R; Adams SA; Salloum RG; Bell N; Arrington AK; Linder SK; Munden RF
Lung Cancer; 2014 Sep; 85(3):379-84. PubMed ID: 25088660
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT.
Zhang EW; Shepard JO; Kuo A; Chintanapakdee W; Keane F; Gainor JF; Mino-Kenudson M; Lanuti M; Lennes IT; Digumarthy SR
Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1472-1479. PubMed ID: 34108138
[TBL] [Abstract][Full Text] [Related]
14. Performance of the cancer risk management model lung cancer screening module.
Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
[TBL] [Abstract][Full Text] [Related]
15. Do Current Lung Cancer Screening Guidelines Apply for Populations With High Prevalence of Granulomatous Disease? Results From the First Brazilian Lung Cancer Screening Trial (BRELT1).
dos Santos RS; Franceschini JP; Chate RC; Ghefter MC; Kay F; Trajano AL; Pereira JR; Succi JE; Fernando HC; Júnior RS
Ann Thorac Surg; 2016 Feb; 101(2):481-6; discussion 487-8. PubMed ID: 26409711
[TBL] [Abstract][Full Text] [Related]
16. CT screening for lung cancer: past and ongoing studies.
Henschke CI; Shaham D; Yankelevitz DF; Altorki NK
Semin Thorac Cardiovasc Surg; 2005; 17(2):99-106. PubMed ID: 16087075
[TBL] [Abstract][Full Text] [Related]
17. CT screening for lung cancer Assessing a regimen's diagnostic performance.
Henschke CI; Yankelevitz DF; Smith JP; Libby D; Pasmantier M; McCauley D; McGuinness G; Naidich DP; Farooqi A; Vasquez M; Miettinen OS
Clin Imaging; 2004; 28(5):317-21. PubMed ID: 15471661
[TBL] [Abstract][Full Text] [Related]
18. The Regimen of Computed Tomography Screening for Lung Cancer: Lessons Learned Over 25 Years From the International Early Lung Cancer Action Program.
Henschke CI; Yip R; Shaham D; Zulueta JJ; Aguayo SM; Reeves AP; Jirapatnakul A; Avila R; Moghanaki D; Yankelevitz DF;
J Thorac Imaging; 2021 Jan; 36(1):6-23. PubMed ID: 32520848
[TBL] [Abstract][Full Text] [Related]
19. CT screening for lung cancer: comparison of three baseline screening protocols.
Henschke CI; Yip R; Ma T; Aguayo SM; Zulueta J; Yankelevitz DF;
Eur Radiol; 2019 Oct; 29(10):5217-5226. PubMed ID: 30511179
[TBL] [Abstract][Full Text] [Related]
20. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP).
Henschke CI; Yip R; Shaham D; Markowitz S; Cervera Deval J; Zulueta JJ; Seijo LM; Aylesworth C; Klingler K; Andaz S; Chin C; Smith JP; Taioli E; Altorki N; Flores RM; Yankelevitz DF;
Radiology; 2023 Nov; 309(2):e231988. PubMed ID: 37934099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
